Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug?

Acute immuno-depression syndrome (AIDs) had been observed in many life-threatening conditions leading to the Intensive Care Unit. and is associated with recurrent secondary infections. We report one COVID-19 patient with a severe ARDS, demonstrating acute immunodepression syndrome lasting for severa...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2023-06, Vol.14, p.1183665
Main Authors: De Waard, Aurianne, Lefebvre, Laurent, Textoris, Julien, Payen, Didier
Format: Article
Language:English
Subjects:
acute immuno-depression syndrome
ARDS (acute respiratory disease syndrome)
Coinfection - drug therapy
COVID 19
HLA-DR
HLA-DR Antigens - metabolism
Humans
Immune Tolerance
Immunology
interferon gamma (IFNγ)
Interferon-gamma - pharmacology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c387t-f2411ff51d018f24088add2319579de278b6c3fe477c2b5b90d00ec38dfa5ef03
container_end_page
container_issue
container_start_page 1183665
container_title Frontiers in immunology
container_volume 14
creator De Waard, Aurianne
Lefebvre, Laurent
Textoris, Julien
Payen, Didier
description Acute immuno-depression syndrome (AIDs) had been observed in many life-threatening conditions leading to the Intensive Care Unit. and is associated with recurrent secondary infections. We report one COVID-19 patient with a severe ARDS, demonstrating acute immunodepression syndrome lasting for several weeks. The occurrence of secondary infections despite long treatment by antibiotics led to combined interferon γ (IFNγ) as reported previously. The response to IFNγ was evaluated by the flowcytometry HLA-DR expression on circulating monocytes, which was repeated from time to time. The severe COVID-19 patients responded well to IFNγ without adverse events.
doi_str_mv 10.3389/fimmu.2023.1183665
format article
fullrecord <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_87b1a8836d6f4adf808e7f27bead8cf1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_87b1a8836d6f4adf808e7f27bead8cf1</doaj_id><sourcerecordid>37359519</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-f2411ff51d018f24088add2319579de278b6c3fe477c2b5b90d00ec38dfa5ef03</originalsourceid><addsrcrecordid>eNpVkd9OHCEUxomxUWN9gV40vMBs-TMMjDfGrLbdxMSk0d4SBg5bzA5sYMZk317WtUa54TvA9wPOh9A3Shacq_6HD-M4LxhhfEGp4l0njtAZ7bq24Yy1xx_0Kboo5YnU0facc3GCTrnkohe0P0O7pSmA_8A25ekSr-IE2c45Q5xwiB7sFFIsVeLl_d_VTUP7JkQ3W3C4zGUyIVa1f0lMDrYZSqnnL3HYWyrKQ04Rr804GmyqI0xm2AB2eV5ffUVfvNkUuHibz9Hjz9uH5e_m7v7Xanl911iu5NR41lLqvaCOUFULopRxjnHaC9k7YFINneUeWiktG8TQE0cIVK_zRoAn_BytDlyXzJPe5jCavNPJBP26kPJamzwFuwGt5ECNqs10nW-N84ookJ7JAYxT1tPKujqwtvMwgrO1TdlsPkE_78TwT6_Ts6aEKVE_UgnsQLA5lZLBv5sp0ftg9Wuweh-sfgu2mr5_vPbd8j9G_gKGF6ML</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug?</title><source>PubMed (Medline)</source><creator>De Waard, Aurianne ; Lefebvre, Laurent ; Textoris, Julien ; Payen, Didier</creator><creatorcontrib>De Waard, Aurianne ; Lefebvre, Laurent ; Textoris, Julien ; Payen, Didier</creatorcontrib><description>Acute immuno-depression syndrome (AIDs) had been observed in many life-threatening conditions leading to the Intensive Care Unit. and is associated with recurrent secondary infections. We report one COVID-19 patient with a severe ARDS, demonstrating acute immunodepression syndrome lasting for several weeks. The occurrence of secondary infections despite long treatment by antibiotics led to combined interferon γ (IFNγ) as reported previously. The response to IFNγ was evaluated by the flowcytometry HLA-DR expression on circulating monocytes, which was repeated from time to time. The severe COVID-19 patients responded well to IFNγ without adverse events.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2023.1183665</identifier><identifier>PMID: 37359519</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>acute immuno-depression syndrome ; ARDS (acute respiratory disease syndrome) ; Coinfection - drug therapy ; COVID 19 ; HLA-DR ; HLA-DR Antigens - metabolism ; Humans ; Immune Tolerance ; Immunology ; interferon gamma (IFNγ) ; Interferon-gamma - pharmacology</subject><ispartof>Frontiers in immunology, 2023-06, Vol.14, p.1183665</ispartof><rights>Copyright © 2023 De Waard, Lefebvre, Textoris and Payen.</rights><rights>Copyright © 2023 De Waard, Lefebvre, Textoris and Payen 2023 De Waard, Lefebvre, Textoris and Payen</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c387t-f2411ff51d018f24088add2319579de278b6c3fe477c2b5b90d00ec38dfa5ef03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285411/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285411/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37359519$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>De Waard, Aurianne</creatorcontrib><creatorcontrib>Lefebvre, Laurent</creatorcontrib><creatorcontrib>Textoris, Julien</creatorcontrib><creatorcontrib>Payen, Didier</creatorcontrib><title>Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug?</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Acute immuno-depression syndrome (AIDs) had been observed in many life-threatening conditions leading to the Intensive Care Unit. and is associated with recurrent secondary infections. We report one COVID-19 patient with a severe ARDS, demonstrating acute immunodepression syndrome lasting for several weeks. The occurrence of secondary infections despite long treatment by antibiotics led to combined interferon γ (IFNγ) as reported previously. The response to IFNγ was evaluated by the flowcytometry HLA-DR expression on circulating monocytes, which was repeated from time to time. The severe COVID-19 patients responded well to IFNγ without adverse events.</description><subject>acute immuno-depression syndrome</subject><subject>ARDS (acute respiratory disease syndrome)</subject><subject>Coinfection - drug therapy</subject><subject>COVID 19</subject><subject>HLA-DR</subject><subject>HLA-DR Antigens - metabolism</subject><subject>Humans</subject><subject>Immune Tolerance</subject><subject>Immunology</subject><subject>interferon gamma (IFNγ)</subject><subject>Interferon-gamma - pharmacology</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkd9OHCEUxomxUWN9gV40vMBs-TMMjDfGrLbdxMSk0d4SBg5bzA5sYMZk317WtUa54TvA9wPOh9A3Shacq_6HD-M4LxhhfEGp4l0njtAZ7bq24Yy1xx_0Kboo5YnU0facc3GCTrnkohe0P0O7pSmA_8A25ekSr-IE2c45Q5xwiB7sFFIsVeLl_d_VTUP7JkQ3W3C4zGUyIVa1f0lMDrYZSqnnL3HYWyrKQ04Rr804GmyqI0xm2AB2eV5ffUVfvNkUuHibz9Hjz9uH5e_m7v7Xanl911iu5NR41lLqvaCOUFULopRxjnHaC9k7YFINneUeWiktG8TQE0cIVK_zRoAn_BytDlyXzJPe5jCavNPJBP26kPJamzwFuwGt5ECNqs10nW-N84ookJ7JAYxT1tPKujqwtvMwgrO1TdlsPkE_78TwT6_Ts6aEKVE_UgnsQLA5lZLBv5sp0ftg9Wuweh-sfgu2mr5_vPbd8j9G_gKGF6ML</recordid><startdate>20230608</startdate><enddate>20230608</enddate><creator>De Waard, Aurianne</creator><creator>Lefebvre, Laurent</creator><creator>Textoris, Julien</creator><creator>Payen, Didier</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230608</creationdate><title>Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug?</title><author>De Waard, Aurianne ; Lefebvre, Laurent ; Textoris, Julien ; Payen, Didier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-f2411ff51d018f24088add2319579de278b6c3fe477c2b5b90d00ec38dfa5ef03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>acute immuno-depression syndrome</topic><topic>ARDS (acute respiratory disease syndrome)</topic><topic>Coinfection - drug therapy</topic><topic>COVID 19</topic><topic>HLA-DR</topic><topic>HLA-DR Antigens - metabolism</topic><topic>Humans</topic><topic>Immune Tolerance</topic><topic>Immunology</topic><topic>interferon gamma (IFNγ)</topic><topic>Interferon-gamma - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>De Waard, Aurianne</creatorcontrib><creatorcontrib>Lefebvre, Laurent</creatorcontrib><creatorcontrib>Textoris, Julien</creatorcontrib><creatorcontrib>Payen, Didier</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>De Waard, Aurianne</au><au>Lefebvre, Laurent</au><au>Textoris, Julien</au><au>Payen, Didier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug?</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2023-06-08</date><risdate>2023</risdate><volume>14</volume><spage>1183665</spage><pages>1183665-</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Acute immuno-depression syndrome (AIDs) had been observed in many life-threatening conditions leading to the Intensive Care Unit. and is associated with recurrent secondary infections. We report one COVID-19 patient with a severe ARDS, demonstrating acute immunodepression syndrome lasting for several weeks. The occurrence of secondary infections despite long treatment by antibiotics led to combined interferon γ (IFNγ) as reported previously. The response to IFNγ was evaluated by the flowcytometry HLA-DR expression on circulating monocytes, which was repeated from time to time. The severe COVID-19 patients responded well to IFNγ without adverse events.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>37359519</pmid><doi>10.3389/fimmu.2023.1183665</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-3224
ispartof Frontiers in immunology, 2023-06, Vol.14, p.1183665
issn 1664-3224
1664-3224
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_87b1a8836d6f4adf808e7f27bead8cf1
source PubMed (Medline)
subjects acute immuno-depression syndrome
ARDS (acute respiratory disease syndrome)
Coinfection - drug therapy
COVID 19
HLA-DR
HLA-DR Antigens - metabolism
Humans
Immune Tolerance
Immunology
interferon gamma (IFNγ)
Interferon-gamma - pharmacology
title Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T16%3A59%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Case%20Report:%20Intercurrent%20infections%20in%20COVID-19-induced%20sustained%20immunodepression:%20is%20interferon%20gamma%20a%20suitable%20drug?&rft.jtitle=Frontiers%20in%20immunology&rft.au=De%20Waard,%20Aurianne&rft.date=2023-06-08&rft.volume=14&rft.spage=1183665&rft.pages=1183665-&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2023.1183665&rft_dat=%3Cpubmed_doaj_%3E37359519%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c387t-f2411ff51d018f24088add2319579de278b6c3fe477c2b5b90d00ec38dfa5ef03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/37359519&rfr_iscdi=true